ES2059504T3 - Analogos de la hormona del crecimiento porcina. - Google Patents

Analogos de la hormona del crecimiento porcina.

Info

Publication number
ES2059504T3
ES2059504T3 ES88302118T ES88302118T ES2059504T3 ES 2059504 T3 ES2059504 T3 ES 2059504T3 ES 88302118 T ES88302118 T ES 88302118T ES 88302118 T ES88302118 T ES 88302118T ES 2059504 T3 ES2059504 T3 ES 2059504T3
Authority
ES
Spain
Prior art keywords
growth hormone
hormone analogs
swine growth
swine
porcine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88302118T
Other languages
English (en)
Inventor
Lawrence M Souza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
SmithKline Beecham Corp
Original Assignee
Amgen Inc
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc, SmithKline Beecham Corp filed Critical Amgen Inc
Application granted granted Critical
Publication of ES2059504T3 publication Critical patent/ES2059504T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01DNA viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)

Abstract

LA INVENCION SE REFIERE A UN ANALOGO DE LA HORMONA DEL CRECIMIENTO PORCINA, QUE RETIENE LAS PROPIEDADES DIABETOGENICAS DISMINUIDORAS DE LA INSULINA Y LIPOLITICAS DE LA HORMONA DEL CRECIMIENTO PORCINA, A LA VEZ QUE ES CAPAZ DE PROMOVER EL CRECIMIENTO DE MAMIFEROS
ES88302118T 1987-03-12 1988-03-10 Analogos de la hormona del crecimiento porcina. Expired - Lifetime ES2059504T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/024,837 US5104806A (en) 1987-03-12 1987-03-12 Porcine growth hormone analogs encoding dna

Publications (1)

Publication Number Publication Date
ES2059504T3 true ES2059504T3 (es) 1994-11-16

Family

ID=21822658

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88302118T Expired - Lifetime ES2059504T3 (es) 1987-03-12 1988-03-10 Analogos de la hormona del crecimiento porcina.

Country Status (14)

Country Link
US (2) US5104806A (es)
EP (1) EP0282319B1 (es)
JP (1) JP2619036B2 (es)
KR (2) KR970009158B1 (es)
CN (1) CN1033759C (es)
AT (1) ATE94903T1 (es)
AU (1) AU614956B2 (es)
CA (1) CA1277933C (es)
DE (1) DE3884241T2 (es)
ES (1) ES2059504T3 (es)
MY (1) MY103229A (es)
PH (1) PH23502A (es)
WO (1) WO1988007091A1 (es)
ZA (1) ZA881751B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104806A (en) * 1987-03-12 1992-04-14 Amgen, Inc. Porcine growth hormone analogs encoding dna
KR910700264A (ko) * 1989-01-19 1991-03-14 로버트 에이. 아미테이지 소마토트로핀 유사물
US5338836A (en) * 1992-07-29 1994-08-16 American Cyanamid Company Biologically active porcine somatotropin polypeptides and methods of using the same
DE4303744A1 (de) * 1993-02-09 1994-08-11 Univ Autonoma De Nuevo Leon Mo Hundewachstumshormon
CN101665788B (zh) * 2009-09-21 2011-11-09 山西大学 人工合成猪生长激素基因及其表达纯化方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0103395A3 (en) * 1982-08-17 1985-05-22 Biogen N.V. Dna sequences, recombinant dna molecules and processes for producing bovine growth hormone-like polypeptides in high yield
CA1341012C (en) * 1982-09-27 2000-06-06 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing swine growth hormone-like polypeptides
AU2092983A (en) * 1982-11-08 1984-05-17 Genentech Inc. Porcine growth hormone produced by recombinant dna technology
US4699897A (en) * 1983-06-04 1987-10-13 Amgen Biologically active peptides structurally related to regions within growth hormones
US4558033A (en) * 1983-06-06 1985-12-10 Amgen Potentiation of the effects of insulin by peptides
US5134120A (en) * 1984-08-03 1992-07-28 Cornell Research Foundation, Inc. Use of growth hormone to enhance porcine weight gain
US5037806A (en) * 1985-02-22 1991-08-06 Monsanto Company Biologically active method using somatotropins
US4861868A (en) * 1985-02-22 1989-08-29 Monsanto Company Production of proteins in procaryotes
US4670249A (en) * 1985-04-12 1987-06-02 International Minerals & Chemical Corp. Growth-promoting compositions
JPS6236183A (ja) * 1985-06-20 1987-02-17 ザ・サルク・インステイチユ−ト・バイオテクノロジ−/インダストリアル・アソシエイツ・インコ−ポレ−テツド サツカロミセス・セレビシエからのポリペプチドの発現および分泌
US4765980A (en) * 1986-04-28 1988-08-23 International Minerals & Chemical Corp. Stabilized porcine growth hormone
US4792546A (en) * 1986-12-05 1988-12-20 American Cyanamid Company Method for increasing weight gains and reducing deposition of fat in animals
GB8701848D0 (en) * 1987-01-28 1987-03-04 Celltech Ltd Polypeptides
JP2580303B2 (ja) * 1987-02-19 1997-02-12 ジ・アップジョン・カンパニー 異種蛋白をコ−ド付けするcDNA類、発現ベクタ−類および宿主類
US5104806A (en) * 1987-03-12 1992-04-14 Amgen, Inc. Porcine growth hormone analogs encoding dna

Also Published As

Publication number Publication date
AU614956B2 (en) 1991-09-19
KR890700673A (ko) 1989-04-26
EP0282319A3 (en) 1989-05-31
KR970009159B1 (ko) 1997-06-07
CN1033759C (zh) 1997-01-08
DE3884241D1 (de) 1993-10-28
JP2619036B2 (ja) 1997-06-11
KR970009158B1 (ko) 1997-06-07
ATE94903T1 (de) 1993-10-15
AU1496988A (en) 1988-10-10
WO1988007091A1 (en) 1988-09-22
DE3884241T2 (de) 1994-01-13
PH23502A (en) 1989-08-16
EP0282319A2 (en) 1988-09-14
CN88102023A (zh) 1988-11-02
US5104806A (en) 1992-04-14
JPH01502480A (ja) 1989-08-31
MY103229A (en) 1993-05-29
ZA881751B (en) 1988-09-01
US5356877A (en) 1994-10-18
CA1277933C (en) 1990-12-18
EP0282319B1 (en) 1993-09-22

Similar Documents

Publication Publication Date Title
EP0301087A4 (en) HEPTAPEPTID.
GR3004229T3 (es)
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
DE69008423D1 (de) Dynamische Fixierung von Schweinsaortaklappen.
EP0266146A3 (en) Absorbable bone plate
DE3878627D1 (de) Zusammensetzung zur oberflaechenbehandlung von kautschuk.
ATE58644T1 (de) Abfahrtsski mit verlaengerter schaufel.
ATE90731T1 (de) De-mannosylteicoplanin-derivate.
ZA883115B (en) Treatment of diabetes
ATE88349T1 (de) Hyperimmunizierte milch gegen bluthochdruck.
ES2059504T3 (es) Analogos de la hormona del crecimiento porcina.
ES2059457T3 (es) Utilizacion de bezafibrato para el tratamiento de la diabetes.
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
ZA873743B (en) Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
ATE130194T1 (de) Subkutane verabreichung des humanen choriongonadotropins.
GR3005231T3 (es)
EP0351017A3 (en) Pharmaceutical composition useful for the treatment of cardiovascular diseases
KR880007091A (ko) 상승적 치료법

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 282319

Country of ref document: ES